NCT06031714 (MoreCCR) is a NA clinical trial of Saliva sampling in Venous Ulcer, sponsored by Assistance Publique - Hôpitaux de Paris.

Who is sponsoring NCT06031714?

NCT06031714 is sponsored by Assistance Publique - Hôpitaux de Paris.

What drugs are being tested in NCT06031714?

Interventions in NCT06031714: Saliva sampling, Blood sampling, Interviews, Clinical examination.

What condition does NCT06031714 study?

NCT06031714 studies Venous Ulcer, Sickle Cell Ulcer, Diabetic Ulcer, Post-partum Women, Mixed Ulcer.

Is NCT06031714 still recruiting?

NCT06031714 is currently recruiting now. Last updated 12 September 2025.

Last reviewed 2025-09-12 · How we verify

NCT06031714: MoreCCR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fetal Cell Receptors Repertoire

Recruiting now NA Last updated 12 September 2025

What this trial tests

NA trial testing Saliva sampling in Venous Ulcer in 160 participants. Currently enrolling.

Timeline

6 February 2024

Primary endpoint
1 July 2026

1 February 2027

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	160
Start date	6 February 2024
Primary completion	1 July 2026
Estimated completion	1 February 2027
Sites	1 location across France

Drugs / interventions tested

Saliva sampling — full drug profile →
Blood sampling — full drug profile →
Interviews
Clinical examination

Conditions studied

Venous Ulcer — all drugs for Venous Ulcer →
Sickle Cell Ulcer — all drugs for Sickle Cell Ulcer →
Diabetic Ulcer — all drugs for Diabetic Ulcer →
Post-partum Women — all drugs for Post-partum Women →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

Eligibility, any sex, with Venous Ulcer or Sickle Cell Ulcer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to describe the transcriptomic profile of foetal cells in post-partum and more specifically to determine which chemokine receptors are overexpressed in foetal cells in post-partum women with wounds To do so, the investigators will isolate foetal cells from the peripheral blood of healthy controls post partum women as well as from post partum women with skin ulcers and then perform RNA sequencing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Saliva sampling

Trials testing the same drug.

NCT06544018 — Circadian Rhythm Deregulation in Patients With CAPS · NA · recruiting
NCT06037421 — Metagenomic Analysis of Bacterial Microbiota in Breast Milk · recruiting
NCT07187323 — Free Amino-acid Composition of Peri-implant and Periodontal Conditions · completed
NCT06469359 — Analyzes of Nasal Tissue-resident Memory Immune Cells and Peripheral Memory Cells Able to Migrate to Airway Tissues (MUC · NA · completed
NCT04988269 — Assessment of Diurnal Salivary Cortisol Production in COVID-19 · completed

Other recruiting trials for Venous Ulcer

Currently open trials in the same condition.

NCT05805137 — Monitoring of Venous Ulcers Using a Bioimpedance Measurement Based Method and System · NA · recruiting

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06031714 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 12 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06031714.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing